Gene · 722
Papers2,921
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,921
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Elevated levels of nitrotyrosine-modified protein adducts and their association with the severity of primary sjogren's syndrome and secondary sjogren's syndrome with rheumatoid arthritis in Taiwanese Patients. | Clin Rheumatol | 2026 | 41174274 | PubTator, text mining | PubMed |
| Differential expression of complement Properdin and Factor H in the placentae and umbilical cords of mothers with Preeclampsia, Gestational Diabetes Mellitus and Recurrent Pregnancy Loss. | Front Immunol | 2025 | 41710025 | PubTator, text mining | PubMed |
| Transcriptomic analysis of identical twins with different onset ages of adrenoleukodystrophy. | Front Neurosci | 2025 | 41245832 | PubTator, text mining | PubMed |
| Identification of C4BPA as a genetically informed drug target in NSCLC: an integrative single-cell and multi-omics study based on the druggable genes. | Hum Genomics | 2025 | 41053817 | PubTator, text mining | PubMed |
| Unraveling the mechanisms of bone diseases: targeting dendritic cells in osteoimmunology for internal homeostasis balance. | Bone Res | 2025 | 41015585 | PubTator, text mining | PubMed |
| Phage receptor binding protein and Fc fragment fusion enhances phagocytosis of Y. enterocolitica. | AMB Express | 2025 | 41003928 | PubTator, text mining | PubMed |
| RNA binding proteins potentially regulate alternative splicing of immune-related genes during the progression of coronary artery disease. | Exp Biol Med (Maywood) | 2025 | 40950552 | PubTator, text mining | PubMed |
| Novel proteomics biomarkers of recurrent pregnancy loss reflect the dysregulation of immune interactions at the maternal-fetal interface. | Front Immunol | 2025 | 40948775 | PubTator, text mining | PubMed |
| Directed-Complement Activation as a Novel Immunotherapeutic Approach for HER2-Breast Cancer. | Immunotargets Ther | 2025 | 40937368 | PubTator, text mining | PubMed |
| The life-and-death struggle between the complement system and pathogens: Mechanisms of elimination, evasion tactics, and translational potential. | Virulence | 2025 | 40905313 | PubTator, text mining | PubMed |
| Identification and validation of a tear fluid-derived protein biomarker signature in patients with amyotrophic lateral sclerosis. | Acta Neuropathol Commun | 2025 | 40898360 | PubTator, text mining | PubMed |
| Platelet-rich plasma (PRP) and the future of male fertility: a path forward for personalized and regenerative therapies. | Stem Cell Res Ther | 2025 | 40898310 | PubTator, text mining | PubMed |
| Shared genetic susceptibility between idiopathic inflammatory myopathies and common B cell lymphoma subtypes found primarily in the human leucocyte antigen region. | RMD Open | 2025 | 40854812 | PubTator, text mining | PubMed |
| Differential plasma proteome analysis reveals key proteins associated with insulin resistance in acne vulgaris patients. | Sci Rep | 2025 | 40790310 | PubTator, text mining | PubMed |
| Distinctive chromosomal, mutational and transcriptional profiling in colon versus rectal cancers. | J Transl Med | 2025 | 40770356 | PubTator, text mining | PubMed |
| Combining mucosal microbiome and host multi-omics data shows prognostic potential in paediatric ulcerative colitis. | Nat Commun | 2025 | 40759968 | PubTator, text mining | PubMed |
| Structural Insights Into Complement Inhibition: Visualizing Distinct Binding Modes of C4b-Binding Protein Complexes With C4b and SAP. | Mol Cell Proteomics | 2025 | 40754140 | PubTator, text mining | PubMed |
| Development of bispecific antibodies that drive selective targeted local complement inhibition on rheumatoid arthritis-related antigens. | Ann Rheum Dis | 2025 | 40683829 | PubTator, text mining | PubMed |
| Unfolded von Willebrand factor binds protein S and reduces anticoagulant activity. | Blood Vessel Thromb Hemost | 2025 | 40519989 | PubTator, text mining | PubMed |
| Precision-Engineered Nano-Electrospray Emitters Enhance Ionization Efficiency for Trap-Assisted Direct Infusion Mass Spectrometry: Application in Plasma Alzheimer's Disease Proteomics. | J Proteome Res | 2025 | 40490927 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/722/papers?page=3